Challenging received wisdom: antidepressants and the placebo effect (Q28474068)

McGill Journal of Medicine

Europe PubMed Central

title

Challenging received wisdom: antidepressants and the placebo effect (English)

0 references

0 references

1 reference

1

0 references

language of work or name

English

0 references

publication date

July 2008

0 references

published in

0 references

volume

11

0 references

issue

2

0 references

page(s)

219-22

0 references

cites work

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582668

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582668

Antidepressant discontinuation syndrome

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582668

Effects of suggestion and conditioning on the action of chemical agents in human subjects; the pharmacology of placebos

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582668

SSRI Antidepressant Medications: Adverse Effects and Tolerability

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582668

Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582668

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582668

How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582668

Gender differences in treatment response to sertraline versus imipramine in chronic depression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582668

The placebo effect: "relatively large" and "robust" enough to survive another assault

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19148327

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Psychological treatments for depression: how do they work?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19148327

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/19148327